ACAD9 treatment with bezafibrate and nicotinamide riboside temporarily stabilizes cardiomyopathy and lactic acidosis
Download
Download
Download
Full text for this resource is not available from the Research Repository.
Export
Van Hove, Johan LK, Friederich, Marisa W, Hock, Daniella H 
ORCID: https://orcid.org/0000-0002-6940-4420, Stroud, David A ORCID: https://orcid.org/0000-0002-2048-3383, Caruana, Nikeisha ORCID: https://orcid.org/0000-0002-0817-1686, Christians, Uwe ORCID: https://orcid.org/0000-0001-7297-147X, Schniedewind, Björn, Michel, Cole R, Reisdorph, Richard ORCID: https://orcid.org/0000-0003-3162-0571, Lopez Gonzalez, Edwin DJ, Brenner, Charles ORCID: https://orcid.org/0000-0002-4955-3226, Donovan, Tonia E, Lee, Jessica C, Chatfield, Kathryn C, Larson, Austin A, Baker, Peter Russell, McCandless, Shawn E ORCID: https://orcid.org/0000-0001-5719-1520 and Moore Burk, Meghan F
(2024)
ACAD9 treatment with bezafibrate and nicotinamide riboside temporarily stabilizes cardiomyopathy and lactic acidosis.
Mitochondrion, 78.
ISSN 1567-7249
Dimensions Badge
Altmetric Badge
| Item type | Article |
| URI | https://vuir.vu.edu.au/id/eprint/48793 |
| DOI | 10.1016/j.mito.2024.101905 |
| Official URL | http://dx.doi.org/10.1016/j.mito.2024.101905 |
| Subjects | Current > FOR (2020) Classification > 3201 Cardiovascular medicine and haematology Current > FOR (2020) Classification > 3214 Pharmacology and pharmaceutical sciences Current > Division/Research > Institute for Health and Sport |
| Keywords | cardiomyopathy; cardiac failure; mitochondrial disorder; bezafibrate; nicotinamide riboside; pharmacokinetic |
| Download/View statistics | View download statistics for this item |
CORE (COnnecting REpositories)